Local News

Ventyx Biosciences Holds Three Immunology Targets

Encinitas-based Ventyx Biosciences, a clinical-stage biotech company developing oral therapeutics for autoimmune disease, has landed a $114 million equity financing to advance its pipeline of immunology programs…

Take 1 minute to subscribe and you’ll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know

Yours for only $99